A new strategy to combat solid tumours with neoantigen-based immunotherapy
Front Line Genomics,
A preclinical study has provided in vitro and in vivo evidence for using mutated KRAS epitopes as a viable target for neoantigen…
A preclinical study has provided in vitro and in vivo evidence for using mutated KRAS epitopes as a viable target for neoantigen…
Colorized scanning electron micrograph of a T lymphocyte. (NIAID) 28 Oct. 2019. A cancer center and biotechnology company are…